MFS
LAB icon

Mirabella Financial Services’s Standard BioTools LAB Stock Holding History

Mirabella Financial Services’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,434,387
Closed -$4.12M – 287
2025
Q2 		$4.12M Buy
3,434,387
+163,714
+5% +$181K 0.42% 48
2025
Q1 		$3.53M Buy
3,270,673
+140,483
+4% +$197K 0.14% 102
2024
Q4 		$5.48M Buy
+3,130,190
New +$5.83M 0.5% 48
2024
Q2 		– Sell
-215,520
Closed -$584K – 573
2024
Q1 		$584K Buy
+215,520
New +$520K 0.04% 258

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Mirabella Financial Services's LAB Position: Q3 2025 in Review

Mirabella Financial Services sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 3,434,387 shares — an estimated $4.12M sold.

Mirabella Financial Services first reported a position in LAB in Q1 2024 and held it in 4 quarters. The position peaked at $5.48M in Q4 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

  • Mirabella Financial Services reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
  • Mirabella Financial Services sold 3,434,387 Standard BioTools shares in Q3 2025, an estimated $4.12M.
  • Mirabella Financial Services first reported a position in Standard BioTools in Q1 2024 and held it in 4 quarters.
  • Mirabella Financial Services's Standard BioTools position peaked at $5.48M in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Mirabella Financial Services's 13F filing for Q3 2025, filed 14 Nov 2025.